ALK inhibitor

Results: 36



#Item
1

PDF Document

Add to Reading List

Source URL: erialcl.net

Language: English - Date: 2015-10-05 11:40:28
2Early Stage researcher (ESR) PhD Projects ESR 1 Investigation of the nuclear functions of ALK Duration: 3 years Start: before August 2016

Early Stage researcher (ESR) PhD Projects ESR 1 Investigation of the nuclear functions of ALK Duration: 3 years Start: before August 2016

Add to Reading List

Source URL: alkatras.erialcl.net

Language: English - Date: 2016-04-15 08:51:39
3Phase (Ph) 1/2a study of TSR-011, a potent inhibitor of ALK and TRK, in advanced solid tumors including crizotinib-resistant ALK positive non-small cell lung cancer PosterHendrik-Tobias Arkenau,1 Jasgit C. Sachdev

Phase (Ph) 1/2a study of TSR-011, a potent inhibitor of ALK and TRK, in advanced solid tumors including crizotinib-resistant ALK positive non-small cell lung cancer PosterHendrik-Tobias Arkenau,1 Jasgit C. Sachdev

Add to Reading List

Source URL: www.tesarobio.com

Language: English - Date: 2015-06-03 16:42:55
    4Cambridges Healthtech Institute´s 22th International Molecular Med Tri-Con 2015 San Francisco, Feb 2015 Enumeration and ALK investigation of circulating tumor cells in non-small cell lung cancer (NSCLC) patients using a

    Cambridges Healthtech Institute´s 22th International Molecular Med Tri-Con 2015 San Francisco, Feb 2015 Enumeration and ALK investigation of circulating tumor cells in non-small cell lung cancer (NSCLC) patients using a

    Add to Reading List

    Source URL: www.gilupi.com

    Language: English - Date: 2015-07-17 05:43:05
    5Cambridges Healthtech Institute´s 22th International Molecular Med Tri-Con 2015 San Francisco, Feb 2015 Enumeration and ALK investigation of circulating tumor cells in non-small cell lung cancer (NSCLC) patients using a

    Cambridges Healthtech Institute´s 22th International Molecular Med Tri-Con 2015 San Francisco, Feb 2015 Enumeration and ALK investigation of circulating tumor cells in non-small cell lung cancer (NSCLC) patients using a

    Add to Reading List

    Source URL: www.gilupi.de

    Language: English - Date: 2015-03-02 07:35:26
    6Example of a scientific poster

    Example of a scientific poster

    Add to Reading List

    Source URL: www.tesarobio.com

    Language: English - Date: 2013-11-07 17:55:14
    7Example of a scientific poster

    Example of a scientific poster

    Add to Reading List

    Source URL: www.tesarobio.com

    Language: English - Date: 2014-11-20 16:15:48
    8ESMOTSR-011, A Potent ALK Inhibitor with Clinical Activity in Phase I/IIa Development Glen J Weiss1, Jasgit C Sachdev2, Jeffrey R Infante3, Monica Mita4, Keith M Wilcoxen5, Vikram Kansra5, David G Brooks5, Robert

    ESMOTSR-011, A Potent ALK Inhibitor with Clinical Activity in Phase I/IIa Development Glen J Weiss1, Jasgit C Sachdev2, Jeffrey R Infante3, Monica Mita4, Keith M Wilcoxen5, Vikram Kansra5, David G Brooks5, Robert

    Add to Reading List

    Source URL: www.tesarobio.com

    Language: English - Date: 2013-09-27 12:02:35
    9Drug Discovery Case History  1. Introduction

    Drug Discovery Case History 1. Introduction

    Add to Reading List

    Source URL: www.brimr.org

    Language: English - Date: 2013-07-01 10:35:04
    10Anaplastic lymphoma kinase (ALK): Structure, oncogenic activation, and pharmacological inhibition

    Anaplastic lymphoma kinase (ALK): Structure, oncogenic activation, and pharmacological inhibition

    Add to Reading List

    Source URL: www.brimr.org

    Language: English - Date: 2012-12-23 16:51:41